Therapeutic cancer vaccines: From initial findings to prospects

Qian Song1, Cheng-Dong Zhang2, Xiang-Hua Wu1

  • 1Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, 130 Dong-An Road, Shanghai 200032, China.

Immunology Letters
|February 7, 2018
PubMed

Insights

Personalized cancer vaccines targeting neoantigens show promise for inducing tumor regression. This review explores therapeutic cancer vaccine strategies and their clinical trial developments.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • The first therapeutic cancer vaccine approval marked a milestone.
  • Numerous therapeutic cancer vaccines are in clinical trials, showing antitumor immune responses.

Purpose of the Study:

  • To review therapeutic cancer vaccine strategies.
  • To highlight personalized cancer vaccines based on neoantigens.
  • To discuss tumor-specific antigen selection methods.

Main Methods:

  • Review of clinical trial data.
  • Analysis of therapeutic cancer vaccine strategies.
  • Focus on neoantigen-based vaccine development.

Main Results:

  • Personalized cancer vaccines demonstrate potential for tumor regression.
  • Neoantigen-based vaccines are an emerging efficient therapeutic approach.

Conclusions:

  • Therapeutic cancer vaccines are advancing, with personalized neoantigen vaccines showing significant promise.
  • Further clinical trials are crucial for demonstrating efficacy.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Vaccinations01:51

Vaccinations

Overview
51.9K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
Initiation of Translation02:33

Initiation of Translation

8.2K
Finding the Center of Gravity01:03

Finding the Center of Gravity

The center of gravity of a body is an imaginary point where the body's total weight is assumed to be concentrated, and the body is perfectly balanced. The center of the mass of a body is a point at which the whole of the mass of the body appears to be concentrated. If the acceleration due to gravity, g, has the same value at all points on a body, its center of gravity is identical to its center of mass. The center of gravity of homogeneous bodies such as a sphere, cube, or rectangular plate...
4.4K
Transcription Initiation01:47

Transcription Initiation

Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.3K